A Concept for Pharmacokinetic- Pharmacodynamic Dosage Adjustment in Renal Impairment: The Case of Aminoglycosides

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.38, Iss.4, 2000-04, pp. : 367-375

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Confounding Issues in Estimation of Patient-Specific Pharmacokinetic Parameters and Dosage Individualization of Aminoglycosides

Current Clinical Pharmacology, Vol. 7, Iss. 1, 2012-02 ,pp. : 28-35

Bentham Science Publishers

Access to resources Recommend Favorite

Adjust valganciclovir dosage in renal impairment

Inpharma, Vol. 1, Iss. 1359, 2002-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Vancomycin Dosage Optimization in Patients with Malignant Haematological Disease by Pharmacokinetic/Pharmacodynamic Analysis

By > > Navarro Amparo Sánchez Dominguez-Gil Alfonso >

Clinical Pharmacokinetics, Vol. 48, Iss. 4, 2009-06 ,pp. : 273-280

Adis International

Access to resources Recommend Favorite

Antiretroviral Drugs and The Kidney: Dosage Adjustment and Renal Tolerance

Current Pharmaceutical Design, Vol. 10, Iss. 32, 2004-12 ,pp. : 4071-4079

Bentham Science Publishers

Access to resources Recommend Favorite

Ximelagatran, melagatran dosage in severe renal impairment

Inpharma, Vol. 1, Iss. 1400, 2003-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite